Related references
Note: Only part of the references are listed.11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors as Promising Therapeutic Drugs for Diabetes: Status and Development
R. Ge et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Obesity and corticosteroids: 11β-Hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease
Nicholas Michael Morton
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
11β-hydroxysteroid dehydrogenase type 1 inhibitors: a review of recent patents
Craig D. Boyle et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2009)
11β-Hydroxysteroid Dehydrogenase Type 1 and Its Role in the Hypothalamus-Pituitary-Adrenal Axis, Metabolic Syndrome, and Inflammation
Mark S. Cooper et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
An in vivo microdialysis coupled with liquid chromatography/tandem mass spectrometry study of cortisol metabolism in monkey adipose tissue
Li Sun et al.
ANALYTICAL BIOCHEMISTRY (2008)
Determination of M+4 stable isotope labeled cortisone and cortisol in human plasma by mu Elution solid-phase extraction and liquid chromatography/tandem mass spectrometry
AY Yang et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2006)
A concise method for the preparation of deuterium-labeled cortisone:: Synthesis of [6,7-2H]cortisone
A Sulima et al.
STEROIDS (2005)
11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice
A Hermanowski-Vosatka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Development and application of a scintillation proximity assay (SPA) for identification of selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1
S Mundt et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2005)
Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11β-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone
TC Sandeep et al.
DIABETES (2005)
Evaluation of 11β-HSD activities in vivo following oral administration of cortisol-13C4,2H1 to a human subject
Y Kasuya et al.
STEROIDS (2003)
Synthesis of [3,4-13C2]-enriched bile salts as NMR probes of protein-ligand interactions
GP Tochtrop et al.
JOURNAL OF ORGANIC CHEMISTRY (2002)
Determination of 11-deoxycortisol (Reichstein's compound S) in human plasma by clinical isotope dilution mass spectrometry using benchtop gas chromatography-mass selective detection
SA Wudy et al.
STEROIDS (2002)
Measurement of cortisol secretion rate by stable isotope methodology following oral administration of 13C-labeled cortisol to a human subject
Y Kasuya et al.
STEROIDS (2002)
Distinguishing the activities of 11 beta-hydroxysteroid dehydrogenases in vivo using isotopically labeled cortisol
R Andrew et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Novel partial synthetic approaches to replace carbons 2,3,4 of steroids.: A methodology to label testosterone and progesterone with 13C in the steroid a ring.: Part 2
K Kockert et al.
TETRAHEDRON (2000)
Novel partial synthetic approaches to replace carbons 2,3,4 of steroids.: A methodology to label testosterone and progesterone with 13C in the steroid a ring.: Part 1
IGJ de Avellar et al.
TETRAHEDRON (2000)
Synthesis of multi-labeled cortisols and cortisones with 2H and 13C for study of cortisol metabolism in humans
T Furuta et al.
STEROIDS (2000)
Share Paper
